In this third blog of The Long-Covid of Pharma Marketing series, we explore the transformed healthcare landscape, where telehealth has emerged as a cornerstone of care delivery.

In this second blog of The Long-Covid of Pharma Marketing series, we investigate one of the most enduring tensions to have grown from the pandemic: misinformation.

This is the first blog of our series on The Long-Covid of Pharma Marketing. Here we’ll revisit the five key tensions that have emerged from and endured beyond the pandemic into pharma marketing’s own long-covid. Today, we explore the growing crisis of vaccine hesitancy and distrust in healthcare.

How one pharmaceutical company used Hidden Methodology to craft a campaign that not only educated patients but empowered them to proactively improve their health.

How one pharmaceutical company moved beyond the typical approach of emphasizing survival, and found success by delving deeper into patients' emotional needs

How a pharmaceutical company navigated unexpected hurdles in launching a cardiovascular (CV) drug that seemed poised to revolutionize the market.

About 95% of our decisions are influenced by unconscious and subconscious emotions. So, understanding what drives consumer people’s decisions is a Holy Grail for marketers. For market researchers, this raises a critical question: how do we unpack these deep-seated decision drivers?

Market research industry veterans Nicola Harte, Scott Kressner, and Soumya Roy, Ph.D. are delighted to announce the launch of their new healthcare-focused insights agency, Integro.